Congrats Dr.PeteFamMed!! Keep going — you're doing incredible. 🎉 👏

Clinical perspective on Oral GLP-1 pipeline overview all agents:

I have managed over 200 patients on GLP-1 therapy and this topic comes up frequently. What the data shows — and what I see in practice — is that proper titration prevents most adverse events.

For this specific question, I would recommend: reviewing the relevant clinical guidelines.

kevin_tulsa said:

Keep going — you're doing incredible

I respect kevin_tulsa perspective but I think this oversimplifies things a bit. Re: Oral GLP-1 pipeline overview — the effect size varies considerably by population.

I am not saying kevin_tulsa wrong entirely — just that the picture is more nuanced than a blanket statement. The SUSTAIN data specifically shows different outcomes in different metabolic phenotypes.

Can confirm — identical experience.

Want to share my personal experience related to Oral GLP-1 pipeline overview since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 255 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 14 months later: I am down 70 lbs, my labs have normalized, and I am off 2 of my 3 medications. The Oral GLP-1 pipeline aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.